← Back to Clinical Trials
Recruiting NCT06385288

Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas

Trial Parameters

Condition Soft Tissue Sarcoma Adult
Sponsor University Hospital Tuebingen
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-07-21
Completion 2026-07-21
Interventions
Blood and tissue collection for immunological studies, advanced imaging.neoadjuvant Therapy

Brief Summary

"Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcoma" is a prospective study with additional translational research using preoperative and postoperative tissue, blood sampling and advanced imaging.

Eligibility Criteria

Inclusion Criteria: * Planned histological confirmation for especially high-risk soft tissue sarcoma via open Sampling * Indication for neoadjuvant multimodal therapy (radiation and locoregional Hyperthermia, optionally with simultaneous chemotherapy) * Planned resection of a department of the CWS * Age \> 18 years * Ability to consent * Additionally for imaging study: Treatment on the combined MR hyperthermia device Exclusion Criteria: * Age \< 18 years * Poor understanding (language etc.) * Lack of reconnaissance ability

Related Trials